HH Biotechnology Holdings Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Sheng Jiang
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8.2yrs |
| CEO ownership | n/a |
| Management average tenure | 8.2yrs |
| Board average tenure | 8.3yrs |
Recent management updates
No updates
Recent updates
No updates
CEO
Sheng Jiang
8.2yrs
Tenure
Mr. Sheng Jiang has been Chief Executive Officer and Director at HH Biotechnology Holdings Company since September 9, 2016.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer and Director | 8.2yrs | no data | no data | |
| Chief Financial Officer | 8.2yrs | US$12.39k | no data | |
| Vice President of Operations | 8.2yrs | no data | no data | |
| Investor Relations Officer | no data | no data | no data | |
| Vice President of Marketing | 8.2yrs | no data | no data |
8.2yrs
Average Tenure
Experienced Management: HHBT's management team is seasoned and experienced (8.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer and Director | 8.2yrs | no data | no data | |
| Chairman | 9.6yrs | no data | no data | |
| Independent Director | 8.5yrs | no data | no data | |
| Director | 8.2yrs | no data | no data |
8.3yrs
Average Tenure
Experienced Board: HHBT's board of directors are considered experienced (8.3 years average tenure).